Peripheral or Central Administration of Motilin Suppresses LH Release in Female Rats: A Novel Role for Motilin by Tsukamura, et al.
Journal of Neuroendocrinology, 2000, Vol. 12, 403–408
Peripheral or Central Administration of Motilin Suppresses LH Release
in Female Rats: A Novel Role for Motilin
H. Tsukamura,* S. Tsukahara,* F. Maekawa,* R. Moriyama,* B. A. S. Reyes,* T. Sakai,† Y. Niwa,* D. L. Foster‡ and
K. -I. Maeda*
*Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
†Laboratory of Cell Biology, Department of Regulation Biology, Faculty of Science, Saitama University, Urawa, Saitama, Japan.
‡Reproductive Sciences Program, Departments of Obstetrics and Gynecology and Biology, University of Michigan, Ann Arbor, MI, USA.
Abstract
Motilin is secreted in a clear episodic pattern during fasting or during the interdigestive phase, but
feeding promptly stops this secretory pattern, and plasma concentrations of motilin decrease. We
have previously determined that fasting markedly suppresses pulsatile luteinizing hormone (LH)
secretion in female rats in the presence of oestrogen. In the present study, we wished to learn if
motilin may mediate the fasting-induced suppression of LH secretion by determining the effects of
motilin administration on LH release and on food intake. Intravenous (i.v.) injection of motilin
(37 nmol/rat) suppressed LH release and significantly decreased mean LH concentrations both in
ovariectomized (OVX) and oestradiol-implanted ovariectomized (OVX+E
2
) rats. Food intake was
significantly increased by i.v. motilin injection in OVX rats, but not in OVX+E
2
rats. It is likely that
motilin inhibits LH release via inhibition of the gonadotrophin-releasing hormone (GnRH)-releasing
mechanism at the hypothalamic level, because motilin (3.7 nmol/rat) also suppressed LH secretion
when centrally administered, and because LH release in i.v. motilin-treated rats increased in
response to exogenous GnRH. These results suggest that motilin may be a peripheral signal for the
suppression of LH secretion through central sensors.
Malnutrition suppresses reproductive function (1–8). We ally considered to be a gastric motor-activity-stimulating
factor (18–20). Plasma motilin concentrations increase withhave determined that 48 h of fasting profoundly suppresses
pulsatile LH secretion in oestrogen-primed ovariectomized a typically episodic secretory pattern at approximately
100-min intervals during fasting in the dog, and feedingrats (9). Reduced glucose availability might, at least in part,
mediate the fasting-induced suppression of LH secretion, reduces the concentrations as well as abolishes the episodic
secretory pattern (21). Among the nutrients, glucose wasbecause pharmacological glucoprivation by 2-deoxyglucose
(2DG) suppresses pulsatile LH release in the rat (10, 11) and found to suppress motilin secretion in the dog and the human
(22, 23). In the rat, a facilitating effect of motilin on feedingsheep (12). This suppression of LH secretion by fasting or
glucoprivation is mediated by noradrenergic neurones pro- behaviour has been reported: both its peripheral administra-
tion in fasted rats and its central administration in non-fastedjecting to the paraventricular nucleus in the hypothalamus to
facilitate the release of corticotrophin-releasing hormone rats increased food intake (24, 25).
The potential role of motilin in the regulation of reproduct-(CRH) (13–16). The noradrenergic inputs to the paraventric-
ular nucleus have also been suggested to induce feeding ive activity is not yet known. However, taken together, the
above findings suggest that motilin could be one of thebehaviour in the rat (17).
Information about glucose availability is provided to the peripheral substances conveying information about fasting or
glucoprivation to the brain to suppress GnRH/LH secretion.brain not only through glucodetectors, but through other
signals as well. One candidate is motilin, which is a 22-amino The present study determined the effect of peripheral and
central administration of motilin on LH secretion.acid peptide found in the gastrointestinal tract, and is gener-
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Materials and methods
Animals and surgery
Wistar-Imamichi female rats, weighing 170–200 g (7–8 months old), were
used. Animals were maintained under controlled conditions (14 L: 10D, lights
on at 05.00 h, temperature at 22±2 °C) with free access to food (Labo-MR-
stock, Nihon Nosan Kogyo Co., Yokohama, Japan) and water. Rats having
shown at least two consecutive 4-day oestrous cycles were used. In all rats
the ovaries were removed surgically (ovariectomized, OVX ), and some of the
females (OVX+E2 group) received oestrogen chronically by means of a
subcutaneously implanted Silastic tubing (i.d., 1.5 mm; o.d., 3.0 mm; length,
25 mm; Dow Corning, Midland, MI, USA) containing oestradiol-17b (E2;Sigma, St Louis, MO, USA) dissolved in peanut oil at 20 mg/ml. We have
previously shown that rats subjected to this E2 treatment had plasma E2concentrations at 35.8±1.2 pg/ml (9), within the range found at dioestrus in
rats (5). To determine the effects of centrally delivered motilin, some OVX+E2rats were implanted with a stainless-steel guide cannula (23 gauge, Plastic
Products Co., Roanoke, VA, USA) with its tip located in the third cerebral
ventricle (0.8 mm posterior and 7.5 mm ventral to bregma at the midline).
They were then allowed to recover from brain surgery for 1 week before the
blood sampling. All surgical procedures were performed under ether
anaesthesia.
Experimental protocol
The effects of motilin were studied in freely moving conscious rats 2 weeks
after OVX and E2 implantation. Synthetic porcine motilin (Peptide Institute,
Osaka, Japan) was dissolved in Ringers solution (in mM, NaCl, 126; KCl, 6;
Na2HPO4, 1; MgSO4, 0.877; NaHCO3, 22; CaCl2, 1.45; -glucose 11.1,
pH 7.4) at a concentration of 37 nmol/200 ml for i.v. or 3.7 nmol/2 ml for i.c.v.
administration. The i.c.v. dose was five times higher than the total dose
previously used to induce food intake (25), and the i.v. dose used in the
present study was 10 times higher than our i.c.v. dose. The motilin solution
or an equal volume of the vehicle was injected after the first hour of blood
sampling. Some OVX+E2 rats with i.v. motilin treatment also received threei.v. injections of gonadotrophin-releasing hormone (GnRH, Sigma). GnRH
(100 ng/kg BW ) was injected every 30 min, starting at 30 min after the i.v.
motilin injection. The dose was based on the findings of previous studies in
which normal size LH pulses were induced by this GnRH treatment (11, 26).
For peripheral administration, motilin and GnRH were injected through the
same cannula as that from which blood was sampled. For i.c.v. administration,
motilin was slowly (1 ml/min) administered into the third ventricle with an
electrical infusion pump (Eicom, Kyoto, Japan) through an inner cannula
inserted into the outer cannula. Food intake was measured by quantifying
the powdered chow consumed during the 3-h sampling period. Blood samples
(100 ml ) were collected at 6-min intervals for 3 h, beginning at 13:00 h,
through Silastic tubing (i.d., 0.5 mm; o.d., 1.0 mm; Shinetsu Polymer Co.,
Tokyo, Japan) which was inserted into the right atrium on the previous day.
An equivalent volume of red blood cells from donor rats was suspended in
saline and replaced through the cannula immediately after each blood sample.
Hormone assay
Plasma LH concentrations were determined by a double-antibody radio-
immunoassay with a rat LH RIA kit provided by the National Hormone and
Pituitary Program (Baltimore, MD, USA) and the levels were expressed in
terms of the reference preparation NIDDK rat LH RP-3. Blood samples
were assayed in 50 ml of plasma, and the least detectable concentration of
LH was 0.156 ng/ml. The intra- and interassay coefficients of variation were
4.2% and 11.4% at the levels of 3.3 ng/ml and 1.5 ng/ml, respectively.
Statistical analysis
Time (h)










































































































Mean plasma LH concentrations in the pre and postinjection periods were F. 1. Effects of i.v. injection of motilin (37 nmol/200 ml ) on LH
calculated for individuals and then for each group. Statistical differences in secretion in ovariectomized (OVX ) and oestradiol-implanted OVX
mean LH concentrations between pre and postinjection in each group and in (OVX+E2) rats. (, ) Representative profiles of plasma LH levels infood intake between vehicle-and motilin-injected groups were determined by OVX () or OVX+E2 () rats, which received i.v. injection (arrows) ofStudent’s paired t-test. motilin or vehicle after the first hour of blood sampling. (,) Mean LH
concentrations (mean±SEM) at pre- and postinjection periods in OVX
() or OVX+E2 ( ) rats. Numbers in each column indicate the numbersResults of the animals used. *P<0.05; **P<0.01 vs pretreated periods (Student’s
t-test).
Effect of i.v. administration of motilin on LH secretion and
food intake
Figure 1, shows representative profiles of plasma LH con-
centrations in OVX and in OVX+E2 rats injected i.v. with
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motilin (37 nmol/rat) or vehicle; Fig. 1, present the group vehicle treatment was not significantly different to the prein-
jection concentration (Fig. 4).mean LH concentrations. In vehicle-treated controls, the
mean LH concentrations in in postinjection period were not
significantly different from those in preinjection periods in
both OVX and OVX+E2 groups. By contrast, in i.v. motilin- Discussioninjected rats, the mean LH concentration in the postinjection
period was significantly lower than in the preinjection period The present study suggests that motilin, a gastrointestinal
hormone, has an inhibitory role in the control of LH secre-(P<0.05 for OVX, and P<0.01 for OVX+E2 groups,Student’s paired t-test). tion. Circulating motilin appears to inhibit LH secretion by
preventing the release of GnRH, rather than by directlyFood intake in the i.v. motilin-injected OVX group was
significantly higher (P<0.01, Student’s t-test) than in vehicle- suppressing LH secretion at the pituitary level, because LH
secretion in response to exogenous GnRH administrationtreated controls, but there was no significant difference within
OVX+E2 groups (Fig. 2). was not affected by peripheral administration of motilin inOVX+E2 rats. In addition, we found that the i.c.v. adminis-tration of motilin immediately suppressed LH release andEffect of GnRH administration on LH release in i.v. motilin-
significantly decreased LH concentrations in OVX+E2 rats.injected OVX+E2 animals Together, these results suggest that peripheral motilin acts on
the central nervous system to suppress GnRH release, and inPlasma LH concentrations were decreased after i.v. motilin
injection alone (Fig. 3, top), while an abrupt increase in LH turn LH secretion.
Perhaps motilin-induced suppression of LH secretionsecretion occurred in response to each GnRH treatment
(Fig. 3, bottom). Overall, the mean plasma LH concentra- shares similar pathways to those mediating fasting-or glucop-
rivation-induced suppression. Motilin secretion from thetion after i.v. motilin injection was significantly (P<0.01)
lower compared with that before the injection (Fig. 3, top); upper digestive tract increases during fasting and decreases
postprandially (21). Glucose administration reduces plasmathe circulating LH concentration was significantly (P<0.05)
higher in motilin-treated rats after the multiple GnRH treat- motilin concentrations and disrupts its episodic pattern of
release. Thus, motilin could be a hunger hormone secretedments (Fig. 3, bottom).
by the digestive tract to convey hunger information to the
central nervous system (CNS), and amongst its other actions,Effect of i.c.v. administration of motilin on LH secretion
it inhibits GnRH secretion to depress gonadal activity.
However, it remains to be determined whether the doses ofThe third ventricular injection of motilin (3.7 nmol/rat) in
OVX+E2 rats immediately suppressed LH secretion, while motilin used in the present study are physiologically and thuswhether they mimic the normal effects of motilin on LHvehicle did not (Fig. 4). Mean LH concentrations after i.c.v.
motilin administration were significantly (P<0.05) lower release.
The vagus nerve is thought to mediate the stimulation ofthan before treatment; the mean LH concentration after
motilin release during fasting; plasma motilin concentrations
are increased by electrical stimulation of the vagus accompan-
ied by an increase in gastrointestinal myoelectric activity in
the dog (27). Atropine attenuates both vagal stimulation-
induced increase in plasma motilin concentrations and epis-
odic pattern of motilin release in fasted animals, resulting in
decrease of the plasma concentrations of this peptide to
baseline level (21). Our previous study revealed that fasting-
induced suppression of LH pulses is reversed by gastric
vagotomy, suggesting that vagus nerve mediates the fasting-
induced suppression of LH release (28). The coincidental
participation of the vagus nerve in both stimulating motilin
release and suppressing LH release during fasting again
suggests that motilin may be involved in the fasting-induced
suppression of pulsatile LH release.
In the present study, food intake was significantly increased
by peripheral motilin injection in OVX rats, but was not
significantly affected in oestrogen-treated OVX rats. The
present result is consistent with a previous result demonstrat-
ing that i.v. motilin administration did not increase food
























F. 2. Effects of i.v. injection of motilin (37 nmol/200 ml ) on food intake intake under fasted condition (24). Thus, gonadal steroids
in ovariectomized (OVX ) and oestradiol-implanted OVX (OVX+E2) may have an inhibitory influence on motilin-induced feedingrats. Food consumption was measured during 3-h sampling period in behaviour. Oestrogen has been suggested to have an anorecticmotilin- or vehicle-treated OVX or OVX+E2 group. Values are action by acting on specific areas of the brain such as themean±SEM. Numbers in/on each column indicate the numbers of the
animals used. **P<0.01 vs vehicle-injected controls (Student’s t-test). preoptic area (29).
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F. 3. Effect of GnRH administration on LH levels after i.v. injection of motilin (37 nmol/200 ml ) in OVX+E2 rats. () Representative profiles ofplasma LH levels in OVX+E2 rats injected with motilin (arrows) after the first hour of blood sampling with ( lower panel ) or without (upper panel )GnRH treatments. GnRH (100 ng/kg BW ) was i.v. injected every 30 min after the motilin treatment. () Mean plasma LH concentrations at pre and
post-motilin injections with ( lower panel ) or without (upper panel ) GnRH administration. Numbers in each column indicate the numbers of the
animals used. *P<0.05; **P<0.01 vs pretreated periods (Student’s t-test).
Because a 22 amino acid peptide may not pass easily varicose fibres was found in the median eminence and
organum vasculosum lamina terminalis, which are majorthrough the blood–brain barrier, its detection by the CNS
may be by the circumventricular organs, which lack or have projection sites of GnRH neurones. Furthermore, immunore-
active fibres were demonstrated in the preoptic area, whereonly a weak blood–brain barrier. Of the circumventricular
organs, the area postrema in particular is thought to have a most GnRH cell bodies are located. These findings, together
with the present findings, imply that motilin might also actmotilin sensing mechanism (30). Moreover, the area postrema
is considered to be an important sensor in relaying informa- as a neuromodulator in the hypothalamus to control GnRH
release.tion about glucose availability to the GnRH-releasing system
(10, 31). Another possibility is that peripheral motilin could In conclusion, the present study suggests that motilin might
be a peripheral signal to suppress reproductive function viabe sensed by peripheral receptors distributed in the upper
digestive tract to convey the information to the CNS through inhibiting GnRH secretion and that central motilin receptors,
at least in part, mediate this inhibition. Increased motilina peripheral neuronal pathway such as the vagus nerve,
because the tract is abundant in motilin-binding sites which release during fasting therefore may mediate the fasting-
induced suppression of LH pulses. However, the site(s) ofis generally considered to play a role in the induction of
gastric motility (32, 33). Motilin might also have a role as a action for suppression of GnRH release by motilin remains
to be clarified.neuromodulator as is known for other brain–gut peptides,
i.e. cholecystokinin or somatostatin. Motilin immunoreactiv-
ity has been found in several regions of the rat brain,
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F. 4. Effect of i.c.v. injection of motilin (3.7 nmol/2 ml ) on LH secretion in OVX+E2 rats. () Profiles of plasma LH levels in OVX+E2 rats, whichreceived i.c.v. injection (arrows) of motilin or vehicle after the first hour of blood sampling. () Mean LH (mean±SEM) at pre- and postinjection
periods. Numbers in each column indicate the numbers of the animals used. *P<0.05 vs pretreated periods (Student’s t-test).
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